Submission format
(A) Review Articles: • Reviews are written by researchers of considerable experience in the field concerned. The authors should review the recent trends or advances in that field in the light of their own work.
• The major portion of the above articles should deal with the up-to-date developments in the field in the 3 – 5 years. Authors are advised to search Medline and other databases on the internet, apartment from collecting information using conventional methods.
• These articles besides should contain a covering letter, title page, summary and keywords. The articles should be written under appropriate sub-headings. The authors are encouraged to use flow charts, boxes, cartoons, tables, photographs of good resolution and figures for better presentation. Some of the other details are given below:

(B) Original Research Articles:
These may either be a full length research article or a short communication. These papers should be arranged into the following sections:
1.Title page with authors name and affiliations
2.Abstract and key words
4.Materials and Methods
10.Tables with captions separately
11.Figures with legends separately

Title page: It should be paginated as page 1 of the paper. It should include the title, authors names and affiliations, running title, address for correspondence including e-mail address and also the total number of pages, figures and tables.

Title: Must be informative, specific, unambiguous and short. It should not exceed 150 characters.

Authors and affiliations: The names of authors and their affiliations should be given. It should be made clear which address relates to which author.

Address for correspondence: The corresponding authors address should be given on the title page. The e-mail ID of the corresponding author or the contact e-mail ID must also be provided.

Abstract and key words: It must start on a new page carrying the following information: (a) Title (without authors names or affiliations), (b) Abstract, (c) Key words, (d) Running title. It should not exceed 250 words excluding the title and the key words. The abstract must be concise, clear and informative rather than indicative. The abstract must be in a structured form and explain briefly what was intended, done, observed and concluded. The conclusions and recommendations not found in the text of the article should not be given in the abstract.

Key Words: Provides 3-5 keywords which will help readers or indexing agencies in cross-indexing the study. The words found in title need not be given as key words. Use terms from the latest Medical Subject Headings (MeSH) list of Index Medicus. A more general term may be used if a suitable MeSH term is not available.

Introduction: It should start on a new page. Essentially this section must introduce the subject and briefly say how the idea for this research topic originated. Give a concise background of the study. Do not review literature extensively but provide the most recent work that has a direct bearing if any on the subject. Justification for research aims and objectives must be clearly mentioned without any ambiguity. The purpose of the study should be stated at the end.

Materials and Methods: This section should deal with the materials used and the methodology (how the work was carried out). The procedure adopted should be described in sufficient detail to allow the experiment to be interpreted and repeated by the readers, if desired. The number of subjects, the number of groups, the study design, sources of drugs with dosage regimen or instruments used, statistical methods and ethical aspects must be mentioned under the section. The data collection procedure must be described. If a procedure is a commonly used, giving a previously published reference would suffice. If a method is not well known (though previously published) it is better to describe it briefly with due acknowledgement. Give explicit descriptions of modifications or new methods so that the readers can judge their accuracy, reproducibility and reliability.

The nomenclature, the source of material and equipment used, with details of the manufacturer in parentheses, should be clearly mentioned. Drugs and chemicals should be precisely identified using their non-proprietary names or generic names. If necessary, the proprietary or commercial name may be inserted once in parentheses. The first letter of the drug name should be small for generic name (e.g., dipyridamole, propranolol) but capitalized for proprietary names (e.g., Persantin, Inderal). New or uncommon drug should be identified by the chemical name and structural formula. The does of drugs should be given as unit weight per kilogram body weight e.g., mg/kg and the concentrations should be given in terms of molarity e.g., nm or mM. The routes of administration may be abbreviated, e.g., intra-arterial (i.a), intracerebroventricular (i.c.v.), intra-gastric gavage (i.g.), intramuscular (i.m.), intraperitoneal (i.p.), intravenous (i.v.), per os (p.o.), subcutaneous (s.c.), transdermal (t.d.)etc.

Statistical Methods: The variation of data should be expressed in terms of the standard error of mean (SEM) or the standard deviation (SD), along with the number of observations (n). The details of statistical tests used and the level of significance should be stated. If more than one test is used it is important to indicate which groups and parameters have been subjected to which test and why.

Results: The results should be stated concisely without comments. They should be presented in logical sequence in the text with appropriate reference to tables and / or figures. The data given in tables or figures should not be repeated in the text. The same data should not be presented in both

tabular and graphic forms. Simple data may be given in the text itself instead of figures or tables. Avoid discussions and conclusions in the results section.

Discussion: This section should deal with the interpretation, rather than recapitulation of results. It is important to discuss the new and significant observations in the light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth. Avoid unqualified statement and conclusions not completely supported by the data. Repetition of information given under Introduction and Results should be avoided.

Conclusions: It must be drawn considering the strengths and weaknesses of the study. Make sure conclusions drawn should agree with the objectives stated under Introduction.

Acknowledgements: These should be typed on a new page. Acknowledge only those who have contributed to the scientific content or provided technical support. Sources of financial support may be mentioned.

References: It should begin on a new page. The number of references should normally be restricted to a maximum of 25 for a full paper. Majority of them should preferably be of articles published in the last 5 years. Papers which have been submitted and accepted but not yet published may be included in the list of references with the name of the journal and indicated as “In press”. Avoid using abstracts as references. The “unpublished observations” and “personal communications” should not be used as references. References are to be cited in the text by superscribed number and should be in the order in which they appear. References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration. As far as possible mentioning names of author(s) for reference should be avoided in the text.

Please note the following examples for a journal article, a chapter in multi-authored book, and a single-authored book respectively. Vega KJ, Pina I, Krevsky B. Heart transplantation is associated with an increased risk for pancreatobiliary disease. Ann Intern Med 1996; 124: 980-3.

More than six authors:
Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E, et al. Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer 1996;73:1006-12.

Entwistle N. In, Excellence in higher education. (De Corte E., ed), 2003; pp. 83-99, Portland Press, London. Bowden A fundamentals of enzyme kinetics, 3rd edn. 2004; Portland Press, London.

Web references: As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired or can be included in the reference list.

Check list for Tables
• Serially numbered in Arabic numerals?
• Short self explanatory heading given?
• Columns have headings?
• Units of data given?
• “n” mentioned?
• Mean ± SD or Mean ± SEM given?
• Statistical significance of groups indicated by asterisks or other markers?
• P values given?
• Rows and columns properly aligned?
• Appropriate position in the text indicated?

Figures: Each figure must be numbered and a short descriptive caption must be provided. A computer drawn figure with good contrast is acceptable. Sometimes, raw data for graphs may be required in Excel sheet when the article is accepted for publication. Graphic files for diagrams and figures may be converted to *.pcx, *.tiff,*.jpg format. These files should not exceed 2 MB in size.

Check list for Figures
• Serially numbered? Self explanatory caption given?
• X and Y axes graduated?
• X and Y axes titled (legend)?
• Units mentioned (if necessary)?
• Different symbols/markers for different groups given?
• SD or SEM represented (graphically)?
• Statistical significance indicated?
• Approximate position in the text marked?

(D) Short/Brief communications: While other things remain the same as described above, these papers should be considerably briefer than Original Articles.

(E) Letter to Editor / Correspondence: This may either be a small research communication or a commentary on a contemporary issue or remarks/queries on a recently published article in NUJHS

(F) Case Reports: Interesting clinical cases (with pharmacologic significance) may be considered for publication. Those with photographs stand a better chance. The case reports should have an unstructured abstract, introduction, case history and a brief discussion.

Send one hard copy of submissions to Dr. Raveendra U. S,
Editor NUJHS,
Journal Office,
K.S. Hegde Medical Academy, Mangalore 575018, India

Editorial Board
Editor-in-Chief: K. R. Shetty,
Editor: Dr. Raveendra U. S,
Associate Editor: M. S. Ravi

Board of Advisors
Rajendra Prasad
C. S. Shastri
Fatima D’Silva
Md Faisal
C. Vaman Rao S
Sudhaker Nayak
Satheesh Kumar Bhandary
Vasudeva Kamath
B. Sundar, Bengaluru
Avinash Shetty, USA
Kapadia, Bahrain
Anupam Agarwal, USA
Deepa Vinu, USA
M. Rajshekar

Editorial Office: Email:


Phone: 0824-2204300 Fax: 824-2204305

Address: Editor, Nitte University Journal of Health Science
University Enclave, Health Science Complex,
Deralakatte, Mangalore 575018, India

The opinions and observations contained the journal are those of the authors/s and not of the NUJHS Editorial Board

Subscription: Annual (4 issues) Rs. 1000 / Single copy: Rs. 300:
For subscriptions or copies contact:

in Index, Google Scholar, GFMER, Nursesmeet, HINARI, Mosbys, getCITED, EBSCOhost, Genamics JournalSeek.

The Nitte University Journal of Health Science (NUJHS) is a peer-reviewed indexed, open access, quarterly research publication. The annual subscription for NUJHS is Rs 1,000/- (4 issues). DDs / Checks payable to Nitte University Journal of Health Sciences, Syndicate Bank, ABSMIDS Branch, Deralakatte can be mailed to Dr. Dr. Raveendra U. S, Editor, NUJHS Journal Office, K. S. Hegde Medical Academy, Mangalore 585018, India. Single copies are available on payment of Rs. 300 each, by cash or check at the Journal Office.